Bank of New York Mellon Corp - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$960,307
+17.3%
250,080
+0.2%
0.00%
Q2 2023$818,812
+282.3%
249,638
+200.7%
0.00%
Q1 2023$214,176
+38.7%
83,0140.0%0.00%
Q4 2022$154,406
-62.4%
83,014
-62.9%
0.00%
Q3 2022$411,000
-12.6%
223,488
+2.1%
0.00%
Q2 2022$470,000
-35.3%
218,887
-5.2%
0.00%
Q1 2022$726,000
-10.4%
231,008
-8.4%
0.00%
Q4 2021$810,000
+104.5%
252,173
+114.6%
0.00%
Q3 2021$396,000
+10.3%
117,500
+27.9%
0.00%
Q2 2021$359,000
-40.9%
91,847
-39.2%
0.00%
Q1 2021$607,000
+93.9%
151,030
+11.7%
0.00%
Q4 2020$313,000
-55.2%
135,263
+11.3%
0.00%
Q3 2020$698,000
-22.7%
121,555
-0.8%
0.00%
Q2 2020$903,000
+1310.9%
122,573
+471.1%
0.00%
Q1 2020$64,000
+4.9%
21,463
-38.1%
0.00%
Q1 2019$61,000
-27.4%
34,650
-0.3%
0.00%
Q4 2018$84,000
-57.4%
34,766
+0.1%
0.00%
Q3 2018$197,000
-20.2%
34,731
+9.6%
0.00%
Q2 2018$247,000
+37.2%
31,695
+24.8%
0.00%
Q1 2018$180,000
+35.3%
25,388
+88.1%
0.00%
Q4 2017$133,000
+20.9%
13,499
+5.1%
0.00%
Q3 2017$110,000
-18.5%
12,838
-0.2%
0.00%
Q2 2017$135,00012,8700.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,000,000$7,820,0004.09%
BVF INC/IL 6,631,051$25,927,0000.97%
EcoR1 Capital, LLC 6,082,200$23,781,0000.89%
GLOBEFLEX CAPITAL L P 1,009,125$3,946,0000.71%
Ikarian Capital, LLC 1,124,872$4,398,0000.36%
CHI Advisors LLC 218,510$854,0000.20%
Artal Group S.A. 2,500,000$9,775,0000.20%
DCF Advisers, LLC 139,701$546,0000.19%
Tibra Equities Europe Ltd 78,700$308,0000.10%
XTX Topco Ltd 50,569$198,0000.07%
View complete list of OVID THERAPEUTICS INC shareholders